-
Mashup Score: 0‘Major improvements’ in diabetes detection in USA - 2 year(s) ago
The number of people with undiagnosed diabetes in the USA has fallen in the past 3 decades, indicates research published in Diabetes Care.
Source: diabetes.medicinematters.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0
Deborah Wexler discusses the findings from GRADE, a head-to-head study comparing glimepiride, sitagliptin, insulin glargine, and liraglutide when used in combination with metformin for the treatment of type 2 diabetes.
Source: diabetes.medicinematters.comCategories: Cardiologists, Latest HeadlinesTweet-
Nice review of GRADE results by one of the investigators https://t.co/RhHjUQo5HJ
-
-
Mashup Score: 0William Polonsky on disengagement with diabetes - 4 year(s) ago
William Polonsky discusses the problem of people being disengaged with their diabetes, why this issue is so critical yet remains so understudied, and what healthcare professionals can do in the clinic to encourage engagement.
Source: diabetes.medicinematters.comCategories: Endocrinology, Latest HeadlinesTweet-
In the sixth podcast in @Diab_Matters series on #psychosocial care in diabetes, William Polonsky discusses #diabetes disengagement, highlighting how healthcare professionals can encourage people with diabetes to engage in self-managing their condition. https://t.co/e34SHG4s1i https://t.co/vWtVLx5NIc
-
-
Mashup Score: 0Kirsty Winkley on optimal medication taking in diabetes - 4 year(s) ago
Kirsty Winkley discusses why people with diabetes can find it so challenging to take medications optimally and consistently, and what healthcare providers can do to help.
Source: diabetes.medicinematters.comCategories: Endocrinology, Latest HeadlinesTweet-
5th podcast in @Diab_Matters series on #psychosocial care in #diabetes: Kirsty Winkley shares her thoughts on the challenges #PWD face in taking medications optimally & consistently, and what approaches HCPs can take to help mitigate potential barriers. https://t.co/NaXQBK5Leo https://t.co/LLLpPrb4bS
-
-
Mashup Score: 1
Adding linagliptin to glimepiride treatment reduces some measures of glycemic variability and improves glycemic control in patients with HNF1A-MODY, indicate findings from the GLIMLINA trial.
Source: diabetes.medicinematters.comCategories: Latest Headlines, RheumatologyTweet-
#EASD2020 news: #Glimepiride–#linagliptin combination shows potential for HNF1A-MODY. Click through to read more about the GLIMLINA trial published in Diabetes Care @ADA_Journals @Stenodiabetes https://t.co/Xra9YBB4Zh
-
-
Mashup Score: 0Christel Hendrieckx on the psychological impact of hypoglycemia - 4 year(s) ago
Christel Hendrieckx discusses the psychological consequences of hypoglycemia in people with diabetes (22:46).
Source: diabetes.medicinematters.comCategories: Endocrinology, Latest HeadlinesTweet-
In the third podcast in @Diab_Matters series on psychosocial care in diabetes, Christel Hendrieckx (@chendrieckx) discusses the impact fear and anxiety surrounding #hypoglycemia can have on #diabetes management, and how best to navigate patient care. https://t.co/3IELeXC67e https://t.co/xjUNm3SO77
-
-
Mashup Score: 0William Polonsky on diabetes distress - 4 year(s) ago
William Polonsky talks about how diabetes distress affects the wellbeing and glucose management of people with diabetes, and what healthcare professionals can do to help.
Source: diabetes.medicinematters.comCategories: Endocrinology, Latest HeadlinesTweet-
In the second podcast in @Diab_Matters series highlighting the role #psychosocial issues play in #diabetes, William Polonsky discusses how healthcare professionals can help alleviate the impact of #DiabetesDistress on glucose management. https://t.co/tJyzndlbUN https://t.co/NOXGDPAk5X
-
-
Mashup Score: 0Why psychosocial research matters - 4 year(s) ago
We highlight the critical role of psychosocial issues in the diabetes care with a series of podcasts examining the latest knowledge in key areas.
Source: diabetes.medicinematters.comCategories: Endocrinology, Latest HeadlinesTweet-
To mark 25 years of the @PSAD_Group, @Diab_Matters highlights the critical role of #psychosocial issues in #diabetes in a series of podcasts. The first episode features PSAD founder Frank Snoek (@diabpsychology). https://t.co/pyDHM8jypT
-
-
Mashup Score: 0
Treatment with canagliflozin is associated with a reduction in the risk for both first and total heart failure events in people with type 2 diabetes and chronic kidney disease, suggests a post-hoc analysis of the CREDENCE trial.
Source: diabetes.medicinematters.comCategories: Cardiologists, Latest HeadlinesTweet-
New CREDENCE analysis of HF - reduction in total events means an even bigger benefit for patients! https://t.co/IrlzB9Btlh
-
-
Mashup Score: 9
The addition of rivaroxaban to aspirin results in a similar relative reduction in the risk for cardiovascular events among patients with stable atherosclerosis and a history of atherosclerotic disease regardless of whether or not they have diabetes, suggests a subgroup analysis of the COMPASS trial.
Source: diabetes.medicinematters.comCategories: CardiologistsTweet-
Add-on rivaroxaban has cardiovascular benefits irrespective of diabetes status https://t.co/WP9BQ1ImjD
-
Number of people with undiagnosed diabetes in U.S. decreased over past three decades https://t.co/LFqIri1SR7